Related Experiment Video
Updated: Jul 20, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Acute Neurological Presentation in Children With SARS-CoV-2 Infection
Antonella Riva1,2, Gianluca Piccolo1,2, Federica Balletti1
1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Insights
SARS-CoV-2 infection in children typically has a benign course. Neurological symptoms, such as headache, are rare and do not correlate with disease severity or pre-existing conditions.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Epidemiology
Background:
- Limited data exists on acute SARS-CoV-2 (COVID-19) presentation in children, especially regarding neurological symptoms.
- Previous reports often comprise small case series, necessitating larger cohort studies.
Purpose of the Study:
- To describe neurological manifestations in a large cohort of pediatric patients with acute SARS-CoV-2 infection.
- To investigate correlations between neurological symptoms, disease severity, and patient demographics.
Main Methods:
- A cohort of 237 children (0-18 years) with confirmed SARS-CoV-2 infection was recruited from April 2020 to March 2021.
- Clinical data, including neurological symptoms, imaging, and laboratory results, were collected and statistically analyzed.
Main Results:
- 13.5% of patients presented with neurological symptoms, most commonly headache (65.6%).
- Neurological symptoms did not significantly impact triage severity or correlate with pre-existing conditions.
- Respiratory and gastrointestinal symptoms were more prevalent in patients without neurological involvement.
Conclusions:
- SARS-CoV-2 infection generally follows a benign course in the pediatric population.
- Neurological manifestations, excluding headache, are uncommon and do not appear to be linked to disease severity or underlying health issues.
Background:
In the pediatric population, the knowledge of the acute presentation of SARS-CoV-2 infection is mainly limited to small series and case reports, particularly when dealing with neurological symptoms. We describe a large cohort of children with acute SARS-CoV-2 infection, focusing on the neurological manifestations and investigating correlations between disease severity and population demographics.
Methods:
Patients aged 0-18 years with a positive molecular swab were recruited between April 2020 and March 2021 from a tertiary Italian pediatric centre. Clinical data, imaging, and laboratory test results were retrieved from our local dataset and statistically analyzed.
Results:
A total of 237 patients with a median age of 3.2 years were eligible; thirty-two (13.5%) presented with neurological symptoms, including headache (65.6%), altered awareness (18.8%), ageusia/anosmia (12.5%), seizures (6.3%), and vertigo (6.3%), combined in 7 (21.9%) cases. Respiratory (59.5%) and gastrointestinal (25.3%) symptoms were the most common among the 205 (86.5%) patients without neurological involvement. Neurological symptoms did not significantly influence the severity of the triage access codes. Moreover, pre-existing medical conditions were not higher in the group with neurological manifestations. Overall, fifty-nine patients (25%, 14/59 with neurological symptoms) required treatment, being antibiotics, systemic steroids, and heparin those most prescribed.
Conclusion:
Our study supports the overall benign course of the SARS-CoV-2 infection in children. Neurological manifestations, except for headache, remain a rare presenting symptom, and disease severity seems unrelated to pre-existing medical conditions.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Coronavirus
Respiratory Syncytial Virus Disease
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction

